pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 30·1 min read
save

Court dismisses part of Lilly lawsuit against Empower, some claims can proceed

A federal judge has dismissed part of Eli Lilly’s lawsuit alleging Empower Pharmacy misled customers about its compounded versions of the obesity drug tirzepatide. But the court said some of Lilly’s claims involving whether Empower ...

Apr 30, 2026·read at Endpoints ↗

April 30, 2026 02:16 PM EDT PharmaLawGLP-1 drugs Court dis­miss­es part of Lil­ly law­suit against com­pounder Em­pow­er, but some claims can pro­ceed Shelby Livingston Health tech correspondent A fed­er­al judge has dis­missed part of Eli Lil­ly’s law­suit al­leg­ing Em­pow­er Phar­ma­cy mis­led cus­tomers about its com­pound­ed ver­sions of the obe­si­ty drug tirzepatide. But … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
87 words · retrieved Apr 30
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLY3ELI LILLY CO
drugs
MOUNJARO2ZEPBOUND2tirzepatide2Obesity
topics
Obesity

related stories

  • Jul 2STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and moreSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 18What’s next for GLP-1 weight loss drugs?STAT
  • Jun 11STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and moreSTAT
  • Jun 8ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ optionBioPharma Dive